SCHEMBL4316384

SCHEMBL4316384

CCOC(=O)COc1c2cc(C(C)(C)C)cc1Cc1cc(C(C)(C)C)cc(c1OCC(=O)OCC)Cc1cc(C(C)(C)C)cc(c1OCC(=O)OCC)Cc1cc(C(C)(C)C)cc(c1OCC(=O)OCC)C2

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CD69 Q07108 3/20 0.68
▸ ELANE P08246 1/20 0.68
▸ TLR4 O00206 3/20 0.49
▸ CD14 P08571 3/20 0.49
▸ LY96 Q9Y6Y9 3/20 0.49
▸ GAA P10253 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ GLA P06280 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ ESR1 P03372 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ NLRP3 Q96P20 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20994043 1.00 CD69 (0.68) CD69ELANETLR4CD14LY96
SCHEMBL29367569 1.00 CD69 (0.68) CD69ELANETLR4CD14LY96
SCHEMBL16545617 0.95 CD69 (0.62) CD69ELANETLR4CD14LY96
SCHEMBL38660826 0.95 CD69 (0.79) CD69ELANETLR4CD14LY96
SCHEMBL28137526 0.85 CD69 (0.72) CD69ELANETLR4CD14LY96
SCHEMBL30279470 0.85 CD69 (0.72) CD69ELANETLR4CD14LY96
SCHEMBL8194998 0.84 CD69 (0.46) CD69ELANEGAAKDM4EALDH1A1
SCHEMBL2217463 0.81 CD69 (1.00) CD69ELANETLR4CD14LY96
SCHEMBL2184946 0.81 CD69 (1.00) CD69ELANETLR4CD14LY96
SCHEMBL14095583 0.81 CD69 (0.67) CD69ELANETLR4CD14LY96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12623942-B2 Method for extracting salts and temperature- regenerated extracting composition ADIONICS (FR) 2026-05-12 — — US disclosed
US-20260042036-A1 METHOD FOR SELECTIVELY EXTRACTING A SALT TO BE EXTRACTED FROM SALTWATER OR BRINE ADIONICS (FR) 2026-02-12 — — US disclosed
EP-3487597-B1 METHOD FOR EXTRACTING SALTS AND TEMPERATURE-REGENERATED EXTRACTING COMPOSITION ADIONICS (FR) 2026-01-21 — — EP disclosed
EP-3808425-B1 METHOD FOR THE DESALINATION OF WATER BY MEANS OF THERMAL DEIONISATION AND LIQUID-PHASE ION EXTRACTION LIQUID ADIONICS (FR) 2025-08-13 — — EP disclosed
EP-4565723-A1 METHOD FOR SELECTIVELY EXTRACTING A SALT TO BE EXTRACTED FROM SALTWATER OR BRINE Adionics (FR) 2025-06-11 — — EP disclosed
CN-119768543-A Method for selectively extracting salt from brine or salt water 艾迪奥尼克斯公司 2025-04-04 — — CN disclosed
CN-113292128-B Apparatus and method for desalting water by thermal deionization and liquid phase ion extraction 艾迪奥尼克斯公司 2024-07-05 — — CN disclosed
WO-2024028786-A1 METHOD FOR SELECTIVELY EXTRACTING A SALT TO BE EXTRACTED FROM SALTWATER OR BRINE ADIONICS (FR) 2024-02-08 — — WO disclosed
US-20230382775-A1 METHOD FOR EXTRACTING SALTS AND TEMPERATURE-REGENERATED EXTRACTING COMPOSITION ADIONICS (FR) 2023-11-30 — — US disclosed
US-11772997-B2 Method for extracting salts and temperature-regenerated extracting composition ADIONICS (FR) 2023-10-03 — — US disclosed
EP-3487597-A1 METHOD FOR EXTRACTING SALTS AND TEMPERATURE-REGENERATED EXTRACTING COMPOSITION Adionics (FR) 2019-05-29 — — EP disclosed
CN-109641160-A Extract the method for salt and the extracts composition of temperature regeneration 艾迪奥尼克斯公司 2019-04-16 — — CN disclosed
US-20180106772-A1 METHOD AND SYSTEM FOR THE DETECTION OF A CHEMICAL SPECIES IN SOLUTION INSTITUT NATIONAL D'OPTIQUE (CA) 2018-04-19 — — US disclosed
US-20180009738-A1 DEVICE AND METHOD FOR THE DESALINATION OF WATER BY MEANS OF THERMAL DEIONISATION AND LIQUID-PHASE ION EXTRACTION LIQUID ADIONICS (FR) 2018-01-11 — — US disclosed
EP-3247677-A1 DEVICE AND METHOD FOR THE DESALINATION OF WATER BY MEANS OF THERMAL DEIONISATION AND LIQUID-PHASE ION EXTRACTION LIQUID ADIONICS (FR) 2017-11-29 — — EP disclosed
CN-107207288-A Apparatus and method for desalination of water by thermal deionization and liquid phase ion extraction 艾迪奥尼克斯公司 2017-09-26 — — CN disclosed
US-7517917-B2 Composition for preparing nanoporous material comprising calixarene derivative SAMSUNG CORNING CO., LTD. (KR) 2009-04-14 — — US disclosed
US-20060094850-A1 Composition for preparing nanoporous material comprising calixarene derivative SAMSUNG CORNING CO., LTD. (KR) 2006-05-04 — — US disclosed
US-6602970-B2 A 2-cyanoacrylate composition has high curing rate and excellent moisture resistance, surface curability containing a cyclic phenol sulfide derivative TOAGOSEI CO., LTD. (JP) 2003-08-05 — — US disclosed
US-20020029848-A1 2-cyanoacrylate composition TOAGOSEI CO., LTD. 2002-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260042036-A1 METHOD FOR SELECTIVELY EXTRACTING A SALT TO BE EXTRACTED FROM SALTWATER OR BRINE PRKAR2B, PRKAR2A, PRKCD CD69 2146/4885ELANE 3034/4885TLR4 4036/4885
US-12623942-B2 Method for extracting salts and temperature- regenerated extracting composition POLQ, NONO, AQP3 CD69 518/4885ELANE 3447/4885TLR4 664/4885
US-20180009738-A1 DEVICE AND METHOD FOR THE DESALINATION OF WATER BY MEANS OF THERMAL DEIONISATION AND LIQUID-PHASE ION EXTRACTION LIQUID AQP3, AQP1, AQP4 CD69 1349/4885ELANE 742/4885TLR4 3607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback